Thyroid Support
This protocol offers integrative support for healthy thyroid function.
Duration: Reassess in 3–4 months. Patient follow-up is at the discretion of the practitioner.
UltraClear® RENEW
-
- Dosing: 2 scoops daily*
- Description: UltraClear® RENEW is formulated to deliver advanced, specialized nutritional support for phase I, II, and III detoxification. Formulated in a base of 14.5 g OptiProtein®—12 g of proprietary, vegan pea/rice protein and 2.5 g of added amino acids—this novel formula features xanthohumol as XNT ProMatrix®, broccoli sprout and floret powder as Brassinase™, and prune and pomegranate extracts to support healthy cellular activities. UltraClear® RENEW also features glycine and magnesium sulfate to support phase II detoxification activities, along with N-acetyl-L-cysteine, green tea catechins, beta-carotene, and vitamins C and E to support healthy antioxidant levels.*
Thyrosol®
-
- Dosing: 1 capsule, three times daily
- Description: Thyrosol® offers a multifaceted approach by providing nutritional support for healthy thyroid function along with additional support for stress-related fatigue.*
PhytoMulti®
-
- Dosing: 2 tablets daily
- Description: PhytoMulti® is a proprietary blend of 13 concentrated extracts and phytonutrients to support cellular health and overall wellness.*
Inflavonoid Intensive Care®
-
- Dosing: 2 capsules daily
- Description: Inflavonoid Intensive Care® features highly bioavailable CurQfen® BSW (curcuminoids, AKBA from Boswellia, and fenugreek) and XNT ProMatrix® (xanthohumol), which may help support the body’s response to oxidative stress, and offers ginger extract, which may help support the body’s immune response.*
D3 Liquid™
-
- Dosing: 1–5 drops daily
- Description: D3 Liquid™ delivers 1,000 IU of vitamin D per drop, supporting vitamin D levels as well as the absorption and utilization of calcium and phosphorus.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Disclaimer
The Fullscript Integrative Medical Advisory team has developed or collected these templates from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this template to your Fullscript template library, you understand and accept that the recommendations in the template are for initial guidance and may not be appropriate for every patient.
Fullscript content philosophy
At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.
Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:
- In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
- Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
- A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
- Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
- All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
- Potential conflicts of interest are clearly disclosed.